Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Allergan PLC, consolidated balance sheet: assets (quarterly data)

US$ in thousands

	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015
Cash and cash equivalents	999,500)	2,503,300)	1,237,500)	1,651,400)	788,500)	880,400)	1,187,900)	1,674,700)	994,800)	1,817,200)	1,612,700)	886,900)	1,092,900)	1,724,000)	7,554,700)	489,500)	2,260,800)	1,096,000)	2,063,900)	1,517,900)	2,114,900)
Marketable securities	1,618,800)	3,411,600)	3,318,400)	322,300)	995,200)	1,026,900)	22,000)	21,500)	1,037,400)	4,632,100)	3,829,100)	4,939,000)	7,858,200)	11,501,500)	19,837,600)	17,100)	13,000)	9,300)	7,000)	8,500)	16,000)
Accounts receivable, net of allowances for doubtful accounts and credit losses	2,800,600)	3,192,300)	3,012,300)	3,086,300)	2,731,200)	2,868,100)	2,826,900)	2,760,800)	2,639,200)	2,899,000)	2,808,600)	2,795,900)	2,542,000)	2,531,000)	2,398,500)	2,490,500)	2,652,800)	2,401,600)	2,143,200)	4,420,100)	3,992,800)
Inventories	1,199,900)	1,133,100)	1,083,100)	1,004,500)	943,200)	846,900)	894,600)	922,500)	948,400)	904,500)	899,800)	935,900)	904,700)	718,000)	705,500)	726,800)	1,022,200)	1,009,700)	1,285,400)	2,786,000)	3,125,100)
Current assets held for sale	—)	—)	—)	—)	45,700)	34,000)	7,300)	—)	—)	—)	—)	—)	—)	—)	455,900)	4,244,000)	3,508,400)	3,540,300)	3,802,100)	38,000)	143,500)
Prepaid expenses and other current assets	855,300)	886,400)	942,300)	2,508,300)	785,500)	819,100)	801,500)	724,200)	773,500)	1,123,900)	962,600)	875,500)	1,302,900)	1,383,400)	771,700)	787,300)	634,300)	558,500)	748,600)	1,004,800)	1,024,100)
Deferred tax assets	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	6,608,500)	711,600)	600,800)
Current assets	7,474,100)	11,126,700)	9,593,600)	8,572,800)	6,289,300)	6,475,400)	5,740,200)	6,103,700)	6,393,300)	11,376,700)	10,112,800)	10,433,200)	13,700,700)	17,857,900)	31,723,900)	8,755,200)	10,091,500)	8,615,400)	16,658,700)	10,486,900)	11,017,200)
Property, plant and equipment, net	1,915,400)	1,926,500)	1,857,000)	1,821,000)	1,781,100)	1,787,000)	1,756,600)	1,761,400)	1,769,500)	1,785,400)	1,802,200)	1,750,100)	1,659,300)	1,611,300)	1,566,300)	1,557,200)	1,602,400)	1,573,900)	1,569,900)	2,859,000)	2,797,900)
Right of use asset, operating leases	481,000)	490,400)	478,200)	457,900)	455,400)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Investments and other assets	430,700)	408,000)	367,900)	335,200)	1,979,500)	1,970,600)	302,800)	297,900)	267,100)	267,900)	269,900)	290,200)	283,200)	282,100)	341,100)	352,600)	405,500)	577,400)	498,300)	530,300)	518,300)
Non current assets held for sale	31,700)	31,700)	32,500)	32,500)	897,200)	882,200)	169,700)	180,400)	71,800)	81,600)	11,100)	11,100)	27,000)	27,000)	207,200)	10,798,000)	10,636,800)	10,541,300)	10,573,700)	—)	—)
Deferred tax assets	597,900)	576,900)	487,400)	689,100)	1,032,600)	1,063,700)	989,400)	899,900)	893,600)	319,100)	327,000)	288,300)	255,400)	233,300)	120,700)	179,500)	77,700)	49,500)	67,200)	113,600)	99,800)
Product rights and other intangibles	36,266,200)	37,890,600)	39,526,800)	41,231,500)	42,264,600)	43,695,400)	48,127,400)	49,928,300)	52,566,500)	54,648,300)	56,698,900)	62,369,700)	62,994,200)	62,618,600)	63,022,700)	64,460,800)	66,535,800)	67,931,700)	67,133,400)	72,825,000)	74,201,100)
Goodwill	41,229,200)	42,248,300)	42,065,500)	42,340,700)	43,336,600)	45,913,300)	49,456,400)	49,687,200)	50,059,500)	49,862,900)	49,770,900)	49,592,200)	47,917,100)	46,356,100)	46,625,800)	46,515,800)	46,724,000)	46,551,500)	46,315,100)	51,596,300)	50,826,400)
Non current assets	80,952,100)	83,572,400)	84,815,300)	86,907,900)	91,747,000)	95,312,200)	100,802,300)	102,755,100)	105,628,000)	106,965,200)	108,880,000)	114,301,600)	113,136,200)	111,128,400)	111,883,800)	123,863,900)	125,982,200)	127,225,300)	126,157,600)	127,924,200)	128,443,500)
Total assets	88,426,200)	94,699,100)	94,408,900)	95,480,700)	98,036,300)	101,787,600)	106,542,500)	108,858,800)	112,021,300)	118,341,900)	118,992,800)	124,734,800)	126,836,900)	128,986,300)	143,607,700)	132,619,100)	136,073,700)	135,840,700)	142,816,300)	138,411,100)	139,460,700)

Total assets exhibited a sustained long-term decline, decreasing from approximately $139.5 billion in March 2015 to $88.4 billion by March 2020. This overall contraction is primarily driven by a reduction in non-current assets, which fell from $128.4 billion to $81.0 billion over the five-year period.

Liquidity and Current Asset Volatility: Current assets demonstrated significant fluctuation, most notably a sharp peak in September 2016 at $31.7 billion. This spike was predominantly caused by a temporary surge in cash and cash equivalents to $7.6 billion and marketable securities to $19.8 billion. Following this peak, current assets generally stabilized between $6 billion and $11 billion, ending the period at $7.5 billion in March 2020. Accounts receivable remained relatively consistent, typically ranging between $2.4 billion and $3.2 billion.
Intangible Assets and Goodwill Trends: A consistent downward trajectory is observed in product rights and other intangibles, which declined from $74.2 billion in March 2015 to $36.3 billion in March 2020. This represents a significant reduction in the asset base, likely attributable to systematic amortization. Goodwill remained relatively stable between $46 billion and $51 billion for the first four years before declining to $41.2 billion by March 2020.
Strategic Asset Divestitures: The data indicates a period of strategic asset reallocation between 2015 and 2016. Significant balances in assets held for sale—both current and non-current—were reported during this timeframe, peaking in September 2015 with combined values exceeding $14 billion. The subsequent disappearance of these balances and the concurrent spike in cash and marketable securities in late 2016 suggest the successful divestiture of these assets.
Fixed and Other Non-Current Assets: Property, plant, and equipment, net, showed a general decline from a high of $2.8 billion in 2015 to $1.9 billion in March 2020. Right-of-use assets for operating leases were introduced into the balance sheet in March 2019, maintaining a steady value between $455 million and $490 million through March 2020. Deferred tax assets showed variability, with a notable non-current increase reaching $1.1 billion in late 2018 before moderating.

Allergan PLC (NYSE:AGN)

Balance Sheet: Assets
Quarterly Data

Assets: Selected Items

Current Assets: Selected Items

Allergan PLC (NYSE:AGN)

Balance Sheet: AssetsQuarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data